Clinical Development 

Clinical Development Services

  • Clinical strategy
  • Study design and sample size calculation
  • BCS Biowaivers
  • Dissolution data analysis, including model fitting and bootstrapping
  • IVIVC
  • Clinical trial project management
  • Nonclinical and clinical overviews
  • Scientific advice meetings

Scientific and Clinical Development 

We focus in scientific and clinical development tailored to our clients’ specific needs, focusing on Value-Added Medicines (VAM) and generic products. Additionally, we are eager to extend our support, project management expertise, and personalized assistance for complex challenges.

We are dedicated to guiding our clients through the complex world of clinical development, devising the most strategic clinical development plans for assured success. Our comprehensive support encompasses study design, robust project management, and expert navigation of projects requiring waived clinical studies or dealing with intricate data demands. Additionally, our expertise shines in orchestrating and participating in scientific advice meetings with regulatory authorities, facilitating a streamlined development process.

To ensure the successful execution of the clinical development plan, we collaborate with a network of highly experienced professionals and reputable Clinical Research Organisations (CROs).

Boasting a history of more than 100 bioequivalence studies carried out under our oversight, we are uniquely equipped to utilize our considerable expertise and deep insights to adeptly handle the challenges of pharmaceutical research and development. Our unwavering commitment to excellence, coupled with our dedication to pioneering innovative solutions, positions us as the prime partner for propelling our clients’ pharmaceutical projects forward.

We offer Clinical Development Services in Athens, Greece

With more than 3,000 sqm of R&D facilities, Adragos Athens specialises in the development of Value Added Medicines and has been recently upgraded with HPAPI capabilities.

Subscribe to our newsletter!

Get notified on our latest news.